Karmele Valencia

1.7k total citations
29 papers, 775 citations indexed

About

Karmele Valencia is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Karmele Valencia has authored 29 papers receiving a total of 775 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 15 papers in Oncology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Karmele Valencia's work include Bone health and treatments (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Karmele Valencia is often cited by papers focused on Bone health and treatments (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Karmele Valencia collaborates with scholars based in Spain, United States and United Kingdom. Karmele Valencia's co-authors include Luis M. Montuenga, Fernando Lecanda, Carolina Zandueta, Susana Martínez-Canarias, C. Ormazábal, Diego Luis-Ravelo, Iker Antón, Javier De Las Rivas, Jackeline Agorreta and Eva Bandrés and has published in prestigious journals such as The Journal of Experimental Medicine, JNCI Journal of the National Cancer Institute and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Karmele Valencia

28 papers receiving 769 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karmele Valencia Spain 16 445 310 265 154 106 29 775
Carmine Fedele United States 12 628 1.4× 214 0.7× 280 1.1× 142 0.9× 148 1.4× 16 870
Iker Antón Spain 9 305 0.7× 214 0.7× 225 0.8× 93 0.6× 49 0.5× 15 538
Tetsuji Sawada Japan 20 494 1.1× 199 0.6× 392 1.5× 138 0.9× 220 2.1× 38 928
Hillary J. Millar United States 9 483 1.1× 150 0.5× 356 1.3× 96 0.6× 246 2.3× 14 773
Maria C. Melander United States 13 175 0.4× 201 0.6× 215 0.8× 61 0.4× 102 1.0× 18 584
Ulrike Lacher Germany 10 631 1.4× 284 0.9× 295 1.1× 88 0.6× 109 1.0× 14 942
Jan Dominik Kuhlmann Germany 18 510 1.1× 486 1.6× 446 1.7× 131 0.9× 185 1.7× 62 1.1k
Chin‐Tung Chen United States 12 387 0.9× 152 0.5× 574 2.2× 259 1.7× 98 0.9× 24 988
María Villalba Spain 20 407 0.9× 232 0.7× 366 1.4× 143 0.9× 341 3.2× 35 959
Christine To Canada 9 391 0.9× 196 0.6× 323 1.2× 173 1.1× 60 0.6× 11 708

Countries citing papers authored by Karmele Valencia

Since Specialization
Citations

This map shows the geographic impact of Karmele Valencia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karmele Valencia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karmele Valencia more than expected).

Fields of papers citing papers by Karmele Valencia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karmele Valencia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karmele Valencia. The network helps show where Karmele Valencia may publish in the future.

Co-authorship network of co-authors of Karmele Valencia

This figure shows the co-authorship network connecting the top 25 collaborators of Karmele Valencia. A scholar is included among the top collaborators of Karmele Valencia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karmele Valencia. Karmele Valencia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sanmamed, Miguel F., Antonio Pineda‐Lucena, Frank Detterbeck, et al.. (2024). Protein Biomarkers in Lung Cancer Screening: Technical Considerations and Feasibility Assessment. Archivos de Bronconeumología. 60. S67–S76. 3 indexed citations
2.
Rodríguez‐Remírez, María, Inés López, Irati Macaya, et al.. (2024). Trametinib sensitizes KRAS-mutant lung adenocarcinoma tumors to PD-1/PD-L1 axis blockade via Id1 downregulation. Molecular Cancer. 23(1). 78–78. 7 indexed citations
3.
Valencia, Karmele, Josefina Casas, Luis Botella, et al.. (2023). Cpt1c Downregulation Causes Plasma Membrane Remodelling and Anthracycline Resistance in Breast Cancer. International Journal of Molecular Sciences. 24(2). 946–946. 10 indexed citations
4.
Cirella, Assunta, Elixabet Bolaños, Carlos Luri‐Rey, et al.. (2023). Intratumoral immunotherapy with mRNAs encoding chimeric protein constructs encompassing IL-12, CD137 agonists, and TGF-β antagonists. Molecular Therapy — Nucleic Acids. 33. 668–682. 6 indexed citations
5.
Arozarena, Imanol, Diego Serrano, Esther Redín, et al.. (2023). Cancer Cell-Intrinsic Alterations Associated with an Immunosuppressive Tumor Microenvironment and Resistance to Immunotherapy in Lung Cancer. Cancers. 15(12). 3076–3076. 11 indexed citations
6.
Moez, Elham Khodayari, Matthew T. Warkentin, Yonathan Brhane, et al.. (2023). Circulating proteome for pulmonary nodule malignancy. JNCI Journal of the National Cancer Institute. 115(9). 1060–1070. 10 indexed citations
7.
Valencia, Karmele, Álvaro Teijeira, Cristina Bértolo, et al.. (2022). DSTYK inhibition increases the sensitivity of lung cancer cells to T cell–mediated cytotoxicity. The Journal of Experimental Medicine. 219(12). 7 indexed citations
8.
Teijeira, Álvaro, Saray Garasa, Carlos Luri‐Rey, et al.. (2022). Depletion of Conventional Type-1 Dendritic Cells in Established Tumors Suppresses Immunotherapy Efficacy. Cancer Research. 82(23). 4373–4385. 22 indexed citations
9.
Moutafi, Myrto, Javier Baena, Ioannis Vathiotis, et al.. (2022). Spatially resolved proteomic profiling identifies tumor cell CD44 as a biomarker associated with sensitivity to PD-1 axis blockade in advanced non-small-cell lung cancer. Journal for ImmunoTherapy of Cancer. 10(8). e004757–e004757. 25 indexed citations
10.
Palanca-Ballester, Cora, Aitor Rodríguez‐Casanova, Susana Torres‐Martínez, et al.. (2021). Cancer Epigenetic Biomarkers in Liquid Biopsy for High Incidence Malignancies. Cancers. 13(12). 3016–3016. 55 indexed citations
11.
Ajona, Daniel, Luis Seijó, Julián Sanz‐Ortega, et al.. (2021). Molecular biomarkers in early stage lung cancer. Translational Lung Cancer Research. 10(2). 1165–1185. 35 indexed citations
12.
Martín-Fernández, Marta, Karmele Valencia, Carolina Zandueta, et al.. (2017). The Usefulness of Bone Biomarkers for Monitoring Treatment Disease: A Comparative Study in Osteolytic and Osteosclerotic Bone Metastasis Models. Translational Oncology. 10(2). 255–261. 8 indexed citations
13.
Zandueta, Carolina, C. Ormazábal, Naiara Perurena, et al.. (2016). Matrix‐Gla protein promotes osteosarcoma lung metastasis and associates with poor prognosis. The Journal of Pathology. 239(4). 438–449. 42 indexed citations
14.
Valencia, Karmele, Diego Luis-Ravelo, Nicolas Bovy, et al.. (2014). miRNA cargo within exosome‐like vesicle transfer influences metastatic bone colonization. Molecular Oncology. 8(3). 689–703. 143 indexed citations
15.
Luis-Ravelo, Diego, Iker Antón, Carolina Zandueta, et al.. (2013). RHOB influences lung adenocarcinoma metastasis and resistance in a host‐sensitive manner. Molecular Oncology. 8(2). 196–206. 23 indexed citations
16.
Luis-Ravelo, Diego, Iker Antón, Carolina Zandueta, et al.. (2013). A gene signature of bone metastatic colonization sensitizes for tumor-induced osteolysis and predicts survival in lung cancer. Oncogene. 33(43). 5090–5099. 35 indexed citations
17.
Valencia, Karmele, C. Ormazábal, Carolina Zandueta, et al.. (2012). Inhibition of Collagen Receptor Discoidin Domain Receptor-1 (DDR1) Reduces Cell Survival, Homing, and Colonization in Lung Cancer Bone Metastasis. Clinical Cancer Research. 18(4). 969–980. 116 indexed citations
18.
Antón, Iker, Diego Luis-Ravelo, Carolina Zandueta, et al.. (2012). Receptor of Activated Protein C Promotes Metastasis and Correlates with Clinical Outcome in Lung Adenocarcinoma. American Journal of Respiratory and Critical Care Medicine. 186(1). 96–105. 45 indexed citations
19.
Valencia, Karmele, Marta Martín-Fernández, Carolina Zandueta, et al.. (2012). miR-326 associates with biochemical markers of bone turnover in lung cancer bone metastasis. Bone. 52(1). 532–539. 42 indexed citations
20.
Luis-Ravelo, Diego, Iker Antón, Silvestre Vicent, et al.. (2011). Tumor–stromal interactions of the bone microenvironment: in vitro findings and potential in vivo relevance in metastatic lung cancer models. Clinical & Experimental Metastasis. 28(8). 779–791. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carmine Fedele Breakdown of academic impact, for papers by Iker Antón Breakdown of academic impact, for papers by Tetsuji Sawada Breakdown of academic impact, for papers by Hillary J. Millar Breakdown of academic impact, for papers by Maria C. Melander Breakdown of academic impact, for papers by Ulrike Lacher Breakdown of academic impact, for papers by Jan Dominik Kuhlmann Breakdown of academic impact, for papers by Chin‐Tung Chen Breakdown of academic impact, for papers by María Villalba Breakdown of academic impact, for papers by Christine To
Rankless by CCL
2026